Precision Business Insights
Portfolio

 

Acute Respiratory Distress Syndrome Disease Pipeline Drugs Assessment

ImageReport NamePrice
Acute Respiratory Distress Syndrome Disease Pipeline Drugs Assessment: Clinical Trials Analysis, Player Profiles, Collaborations, Key Targets, Geographic Focus, and Data Publications, 2018$ 2,000.00$ 6,000.0036200000